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Abstract
Background: Wellens’ syndrome is known to be associated with left anterior descending artery occlusion that
could lead to an extensive anterior wall myocardial infarction. Thus, emergency cardiac catheterization is needed.
However, during coronavirus disease 2019 (COVID-19) pandemic, it is recommended for hemodynamically stable
acute coronary syndrome patients with COVID-19 infection to be treated conservatively in an isolated hospital
ward.
Case presentation: We report an 85-year-old patient with chief complaints of typical, squeezing chest pain in the
past 4 h. The patient had a high fever, dyspnea, sore throat, and fatigue for 3 days. He had previously come into
contact with COVID-19 positive relatives. The patient was hemodynamically stable and pulmonary auscultation
revealed coarse rales in the entire lung. Electrocardiography (ECG) evaluation during the pain episode showed non-
specific ST-T changes in lead V2-V5. After sublingual nitrate was administered, ECG evaluation during the pain-free
period revealed a biphasic T wave inversion in lead V2 and V3. Laboratory workup showed elevated cardiac marker
and leucopenia with neutrophilia and lymphopenia. Rapid immunochromatographic test and initial severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) reverse transcription-polymerase chain reaction (RT-PCR) evaluation
from nasopharyngeal swab showed negative results. However, radiographic evaluations suggest the diagnosis of
COVID-19 infection. While waiting for the second RT-PCR evaluation, the patient was diagnosed with Wellens’
syndrome with suspected COVID-19 infection. The patient was treated conservatively according to national guidelines
and scheduled for elective cardiac catheterization. On the third day, the patient felt better and insisted on being
discharged home. Ten days after discharged, the patient died of myocardial infarction.
Conclusion: Emergency cardiac catheterization should be done for patient with Wellens’ syndrome, regardless of the
COVID-19 infection status.
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Background
Wellens’ syndrome was first reported in 1982 and is
known to be associated with left anterior descending
(LAD) artery occlusion. If left untreated, it could lead to
an extensive anterior wall myocardial infarction [1]. A
later study with 18months follow-up period showed that
the mortality rate was remarkably high in patients
treated conservatively compared to patients treated with
cardiac catheterization (26.67% vs. 0.88%) [2]. Thus,
emergency cardiac catheterization is warranted in pa-
tients presenting with this syndrome.
However, during this coronavirus disease 2019
(COVID-19) pandemic, more caution is taken into con-
sideration for all invasive procedures, including for the
cardiac catheterization procedure. In patients with
COVID-19 infection, the balance of staff exposure and
patient benefit should be weighed carefully. Based on the
patient’s risk, conservative therapy may be sufficient for
non-ST-segment elevation myocardial infarction (NSTE
MI) patient with COVID-19 [3]. The Indonesian Heart
Association also published a national practical clinical
guideline for NSTEMI patient with COVID-19. It is rec-
ommended that patients with stable hemodynamic to be
treated conservatively in isolated hospital ward [4]. In
this report, we present a patient with Wellens’ syndrome
with suspected COVID-19 infection based on the clinical
symptoms and radiographic findings. The patient was
treated conservatively according to the national guide-
line for NSTEMI with COVID-19 infection.
Case presentation
An 85-year-old man came to the emergency room with
the chief complaint of typical, squeezing chest pain in
the past 4 h. The patient also experienced diaphoresis
and nausea following chest pain. In the past 3 days, the
patient had a high fever, dyspnea, sore throat, and fa-
tigue. Past medical history of type 2 diabetes mellitus or
hypertension was denied. He had a history of contact
with one of his relatives who tested positive for severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
based on reverse transcription-polymerase chain reac-
tion (RT-PCR) evaluation.
Vital signs on admission were as follows: blood pres-
sure 130/90 mmHg, respiratory rates 26 times/min, heart
rate 104 beats/min, right axillary temperature 39 °C, oxy-
gen saturation 94% at room air, and became 99% with
the simple mask with 6 L/min oxygen. Pulmonary aus-
cultation revealed coarse rales in the entire lung. Other
physical examinations were within normal limit. Twelve-
lead electrocardiography (ECG) performed when the
patient was in pain showed non-specific ST-T changes
in lead V2-V5 (Fig. 1a). After receiving sublingual ni-
trate, the chest pain subsided, and the ECG evaluation
showed biphasic T wave inversion and minimally ele-
vated ST-segment in lead V2 and V3 (Fig. 1b). Before
the patient was transferred to the hospital ward, the
ECG evaluation in pain-free period revealed deeply
inverted T waves in lead V2-V4 (Fig. 1c).
Laboratory evaluation revealed leucopenia (3.88 × 103/
μl) with neutrophilia (89.4%) and lymphopenia (3.6%),
thrombocytopenia (102 × 103/μl), elevated aspartate
transaminase (AST) (80.3 U/L), and slightly elevated ala-
nine aminotransferase (ALT) (44.4 U/L). Creatine kinase
myocardial band (CK-MB) was also increased (10.4 ng/
mL). Serum creatinine and blood glass analysis were
within normal limits. The Global Registry of Acute
Fig. 1 Electrocardiography evaluation (a) performed on admission in the emergency room during pain period showed non-specific ST-T changes
in lead V2-V5, (b) performed on the painless period after sublingual nitrate showed biphasic T waves inversions and minimally elevated ST
segment in lead V2 and V3, (c) performed before transferred to hospital ward during the painless period showed deeply inverted T waves in
leads V2-V4
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Coronary Events (GRACE) score was 159 and CRUS
ADE bleeding score was 37. Chest X-ray showed preced-
ing consolidation persisted with new consolidative
changes in the left apical-middle-lower zone and the
right lower peripheral region (Fig. 2). Chest computed
tomography scan (CT scan) revealed diffuse pneumonia
in both lungs with multifocal ground-glass opacities and
crazy paving patterns (Fig. 3), a common finding in pa-
tients with COVID-19 infection. However, SARS-CoV-2
rapid immunochromatographic test (Wondfo Biotech,
Guangzhou, China) showed a non-reactive result. The
initial RT-PCR assay (Abbott RealTime SARS-CoV-2
assay, Abbott Molecular Inc., Illinois, USA) from naso-
pharyngeal swab was then performed, but it also showed
a negative result.
Since the diagnosis of COVID-19 infection could not
be ruled out until the RT-PCR assay was repeated, the
patient was diagnosed with Wellens’ syndrome with sus-
pected COVID-19 infection. Because the patient was
categorized as high-risk NSTEMI (high GRACE score
but with stable hemodynamic) with high neutrophil-to-
lymphocyte ratio and suspected with COVID-19 infec-
tion, the patient was treated conservatively in the inten-
sive care unit (ICU) isolation ward while waiting for the
early elective cardiac catheterization. The patient re-
ceived double antiplatelet therapy (DAPT) of aspirin (80
mg once daily) and clopidogrel (75 mg once daily), fon-
daparinux (2.5 mg once daily), atorvastatin (80 mg once
daily), bisoprolol (2.5 mg once daily), isosorbide dinitrate
pump (1 mg per hour), paracetamol (500 mg thrice
daily), and methisoprinol (500 mg thrice daily).
On the third day, the patient’s oxygen saturation was 98%
without oxygen supplementation, and ECG evaluation re-
verts to biphasic T wave in lead V2 and V3 (Fig. 4). CK-MB
level was still above the normal limit (19 ng/mL). The pa-
tient insisted on being discharged and refused to be referred
for early elective cardiac catheterization because he already
felt better. The patient and his family signed the consent
form to be discharged home despite the high chance of
myocardial infarction in the near future. The patient was
also aware that the diagnosis of COVID-19 infection could
not be ruled out yet because second RT-PCR from naso-
pharyngeal swab had not been performed yet, thus he and
his family had to self-quarantine at home for 14 days.
On the fourth day, the patient was discharged and re-
ceived aspirin (80 mg once daily) and clopidogrel (75 mg
once daily) for his take-home medicine. Two weeks later,
in a follow-up session via telephone, one of the family
members informed that the patient already died 10 days
after being discharged from our hospital due to cardiac
arrest secondary to new-onset ST-elevation myocardial
infarction. Due to the limited facilities in the other hos-
pital, the patient did not undergo coronary angiography.
Discussion
Our patient has fulfilled the suspect case criteria for
COVID-19 by WHO guideline as followed: A patient
with acute respiratory illness (fever and at least one
sign/symptom of respiratory disease, e.g., cough, short-
ness of breath), AND a history of travel to or residence
in a location reporting community transmission of
COVID-19 disease or having been in contact with a con-
firmed or probable COVID-19 case during the 14 days
prior to symptom onset or patients with severe acute re-
spiratory illness (fever and at least one sign/symptom of
Fig. 2 Chest X-ray showed preceding consolidation persisted with
new consolidative changes in the left apical-middle-lower zone and
the right lower peripheral region
Fig. 3 Chest computed tomography scan showed diffuse pneumonia
in both lungs with multifocal ground-glass opacities and crazy
paving patterns
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respiratory disease, e.g., cough, shortness of breath;
AND requiring hospitalization) AND in the absence of
an alternative diagnosis that thoroughly explains the
clinical presentation [5]. This was also supported by the
laboratory abnormalities found in our patient, which
were lymphopenia, leucopenia, thrombocytopenia, ele-
vated creatinine, AST and ALT, and hypoxemia from
blood gas analysis, and also pneumonia by chest X-ray
and CT scan findings (bilateral, peripheral, patchy opaci-
ties on chest X-ray and bilateral ground-glass opacities,
crazy paving, and multifocal consolidation from chest
CT scan) that suggest high probable for COVID-19 in-
fection. It is suggested that findings from chest CT scans
usually peak around 9–13 days [6, 7].
WHO criteria for confirmed COVID-19 was based on
the detection of unique sequences of virus SARS-CoV-2
RNA by nucleic acid amplification tests such as real-
time RT-PCR and needed at least two positive results
[8]. For initial diagnostic testing, Centers for Disease
Control and Prevention (CDC) recommends collecting
and testing an upper respiratory specimen with a naso-
pharyngeal swab as the preferred specimen choice [9].
However, multiple negative tests are required to exclude
a diagnosis of COVID-19.
CDC also stated that negative SARS-CoV-2 results
from RT-PCR do not preclude COVID-19 infection and
should not be used as the sole basis for patient treat-
ment decisions, especially when it is not supported with
the clinical observations, patient history, and epidemio-
logical information [9]. It is because RT-PCR has the
sensitivity as low as 6-70% for initial diagnosis despite its
high specificity [10]. In our case, although the initial
SARS-CoV-2 RT-PCR showed a negative result, the
chest CT scan showed a typical manifestation of
COVID-19. This might be explained by the findings
from previous study that the sensitivity of the initial
chest CT scan is greater than the initial RT-PCR assay
(98% vs 71%, p < 0.001) [11].
To establish the diagnosis of Wellens’ syndrome, it is
suggested that several criteria be fulfilled, which includes
(1) deep symmetrically inverted T waves or biphasic T
waves in lead V2 and V3, (2) isoelectric or minimally el-
evated (< 1 mm) ST-segment, (3) absence of precordial
Q waves, (4) history of angina, (5) pattern present during
pain-free period, and (6) normal or mildly elevated cre-
atine phosphokinase (less than two times normal upper
limit) [12]. In our case, the patient fulfilled all criteria
for Wellens’ syndrome except the cardiac marker. How-
ever, since the cardiac marker is known to be frequently
abnormal in patients with COVID-19 [13], we argued
that the cardiac marker criterion could be exempted in
this situation.
There were some reports regarding the association be-
tween COVID-19 infection and cardiovascular complica-
tions including myocardial injury, myocarditis, deep vein
thrombosis (DVT), and pulmonary embolism (PE) [14].
Our case might be correlated to COVID-19 infection-
induced myocardial injury, infarction, or inflammation
due to systemic inflammation response, marked by an
elevated CK-MB level. However, it is unlikely that our
patient had DVT because there were no supporting clin-
ical findings such as warmth or pain in the extremity or
asymmetrical swelling [15]. PE could also be ruled out
because there was also no filling defect in the pulmonary
artery in the chest CT scan evaluation [16].
It could be argued that this type of case is usually diag-
nosed as high-risk anterior NSTEMI. However, we
would like to stress out the use of Wellens’ syndrome
nomenclature to underline the high probability of total
or near-total LAD occlusion that is not commonly found
in high-risk NSTEMI patients. Patients with Wellens’
syndrome will develop extensive anterior wall infarction
Fig. 4 Electrocardiography re-evaluation on the third day showed biphasic T waves in lead V2 and V3
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if aggressive intervention is not undertaken, despite the
relief of symptoms with medical management. Half of
the patients will develop the infarction within 1 week
after the admission [1]. Thus, in normal situation, our
patient should have undergone emergency cardiac
catheterization. Other than that, our patient also had
a GRACE score of 159. European Society of Cardi-
ology (ESC) and American College of Cardiology/
American Heart Association recommend an invasive
strategy should be performed in less than 24 h in pa-
tient with high-risk NSTEMI (GRACE score more
than 140) [17, 18].
However, in patients with suspected COVID-19 infec-
tion, the algorithm management is different. National
guideline published by the Indonesian Heart Association
recommends conservative treatment in the isolated hos-
pital ward if the patients have stable hemodynamic to re-
duce transmission risk of COVID-19, especially when a
special standardized facility is not available [4]. This rec-
ommendation was in line with the Chinese Society of
Cardiology guideline that recommends patients with
high-risk NSTEMI to be hospitalized and treated conser-
vatively in designated hospital [19]. American College of
Cardiology suggests that in patient with stable NSTEMI,
conservative therapy may be sufficient on the basis of
patient risk [3]. In contrary, guideline published by ESC
recommends patients with high-risk NSTEMI to still be
treated with an early invasive strategy in less than 24 h
after admission in COVID-19 designated hospital [20].
According to the Egyptian Society of Cardiology guide-
lines, patients with high-risk NSTEMI should undergo
early catheterization in less than 24 h. However, it is only
possible if the hospital is not overwhelmed and all the
precautions to prevent the dissemination of infection
and protect the medical staff are adopted. Nevertheless,
if the prevalence of COVID-19 increases and causes
overburden of the health system resources, patients with
high-risk NSTEMI should be hospitalized and treated
conservatively in isolation wards or ICU in non-
designated hospital [21].
According to the national guideline, DAPT (clopido-
grel or ticagrelor and aspirin) and high-dose statin
should be given for conservative treatment during
hospitalization [4]. We opted to treat our patient with
clopidogrel because of the moderate bleeding risk
(CRUSADE score 37). Recent meta-analysis study
showed that ticagrelor was associated with a higher risk
of major bleeding compared to clopidogrel in East Asian
patients with acute coronary syndrome [22]. In addition
to those recommended treatment, the patient also re-
ceived fondaparinux. After the hospitalization, the pa-
tient had been given DAPT for take-home medicine. It
is recommended that DAPT should be given for 1 year
after discharged home [17].
The limitations of this report were the absence of cor-
onary angiography and echocardiography evaluation.
Therefore, the diagnosis of the patients could not be
confirmed and the differential diagnosis such as PE and
myocarditis could not be totally excluded. The coronary
angiography was not performed because it was not rec-
ommended by the Indonesian Heart Association. Echo-
cardiography evaluation was not performed because
there was no published guideline in performing echocar-
diography to patients with suspected COVID-19 infec-
tion and there was also a shortage of standardized
personal protective equipment when this case report
occurred.
Conclusion
In the case of acute coronary syndrome in the COVID-
19 pandemic situation where the risk of infectious
spread is very high, risk stratification is essential to de-
termine the treatment strategy. Following the national
guideline in this situation, high-risk NSTEMI with con-
servative management is preferred for treatment in the
acute phase, with favorable outcomes in the acute phase.
However, in the case of Wellens’ syndrome, where sig-
nificant LAD occlusion is suspected, urgent early cardiac
catheterization should be done, regardless of the
COVID-19 infection status. Recognition of the ECG pat-
tern of Wellens’ syndrome is also crucial because Well-
ens’ syndrome has a poor prognosis despite the lack of
symptoms in early stable conditions.
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